Zhiyong Yang

Zhiyong Yang currently serves as a Scientific Director in External Innovation and Drug Discovery at Novo Nordisk since July 2024. Prior to this role, Zhiyong was with Johnson & Johnson from July 2018 to July 2024 as a Director of Biology and Program Lead, where successful leadership of two high-priority drug discovery programs was achieved, including a notable program progressing to Ph1b clinical trial planning in 2023. Zhiyong's earlier experience at Pfizer spanned 18 years, during which progress from Senior Scientist to Senior Principal Scientist and Project Leader was made, overseeing collaborative project teams across various disciplines. Zhiyong holds postdoctoral fellowships from Harvard Medical School, focusing on Innate Immunity and Inflammation, as well as from Yale School of Medicine, specializing in Molecular and Cell Biology.